Literature DB >> 207239

Resistance to vaginal or systemic infection with herpes simplex virus type 2.

M C Breinig, L L Wright, M B McGeorge, P S Morahan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207239     DOI: 10.1007/bf01315634

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  23 in total

1.  Thymus dependence of viral antigens.

Authors:  W Burns; L C Billups; A L Notkins
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

2.  Genital herpesvirus hominis infection in mice. I. Development of an experimental model.

Authors:  J C Overall; E R Kern; R L Schlitzer; S B Friedman; L A Glasgow
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

3.  Comparison of antiviral and antitumor activity of activated macrophages.

Authors:  P S Morahan; L A Glasgow; J L Crane; E R Kern
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

4.  Immunomodulator-induced resistance against herpes simplex virus.

Authors:  P S Morahan; E R Kern; L A Glasgow
Journal:  Proc Soc Exp Biol Med       Date:  1977-04

5.  Recurrent herpes genitalis. Treatment with Mycobacterium bovis (BCG).

Authors:  F D Anderson; R N Ushijima; C L Larson
Journal:  Obstet Gynecol       Date:  1974-06       Impact factor: 7.661

6.  Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.

Authors:  M S Paranjpe; C W Boone
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506

7.  Macrophages and age-dependent resistance to Herpes simplex virus in mice.

Authors:  M S Hirsch; B Zisman; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

8.  Stimulation of antibody formation by pyran copolymer.

Authors:  W Braun; W Regelson; Y Yajima; M Ishizuka
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

9.  Herpesvirus hominis type 2 infections in rabbits: effect of prior immunization with attenuated Mycobacterium bovis (BCG) cells.

Authors:  C L Larson; R N Ushijima; R Karim; M B Baker; R E Baker
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

10.  Pyran and polyribonucleotides: differences in biological activities.

Authors:  P S Morahan; W Regelson; A E Munson
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

View more
  7 in total

1.  Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections.

Authors:  M B McGeorge; P S Morahan
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

2.  The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice.

Authors:  K E Schneweis; J Gruber; J Hilfenhaus; A Möslein; M Kayser; M H Wolff
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

3.  Criteria for development of animal models of diseases of the reproductive system.

Authors:  L B Corbeil
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

4.  Activated porcine alveolar macrophages: are biological response modifiers the answer?

Authors:  S K Chapes; C G Chitko; R C Thaler; J L Nelssen; G A Anderson; F Blecha
Journal:  Vet Immunol Immunopathol       Date:  1989-08       Impact factor: 2.046

5.  Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.

Authors:  M R McDermott; J R Smiley; P Leslie; J Brais; H E Rudzroga; J Bienenstock
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

6.  Effect of pyran on latency after herpes simplex virus infections.

Authors:  P S Morahan; P F Cline; M C Breinig; B K Murray
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

7.  Approaches to assessing host resistance.

Authors:  S G Bradley; P S Morahan
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.